193 results on '"Kaddu‐Mulindwa, Dominic"'
Search Results
2. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas
3. PLWH treated with modern ART and high CD4 T cell counts: no evidence of HIV-associated vasculopathy measured by extra- and intracranial ultrasound
4. Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
5. Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma
6. Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.
7. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study.
8. KIR2DS1–HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
9. LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
10. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
11. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy
12. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
13. Primary HIV infection presenting with Kaposi sarcoma and limbic encephalitis
14. Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
15. Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
16. A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation
17. Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
18. Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R) - CHOP
19. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
20. Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
21. Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2
22. Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis
23. Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization
24. Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
25. Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization
26. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
27. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients
28. Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
29. Advances in Lymphoma Molecular Diagnostics
30. IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study
31. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors
32. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial
33. Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19
34. A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)
35. Additional file 1 of Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
36. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
37. Current Treatment Options in CLL
38. Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection
39. Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
40. Drug adherence and psychosocial characteristics of patients presenting with hypertensive urgency at the emergency department
41. Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis
42. IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study.
43. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
44. VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma
45. Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
46. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy
47. Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection
48. 330 LIVER STIFFNESS MEASUREMENTS IN EMERGENCY TRIAGE PREDICT INPATIENT HEALTH CARE UTILIZATION
49. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial.
50. Primary HIV infection presenting with Kaposi sarcoma and limbic encephalitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.